Key Takeaways:
Cerus Corporation (CERS) expanded its global reach in 2025, distributing 3 million doses of INTERCEPT-treated blood components across 40 coun
Cerus Corporation (CERS) expanded its global reach in 2025, distributing 3 million doses of INTERCEPT-treated blood components across 40 coun






